InDex Pharmaceuticals Holding AB (publ) reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was SEK 41.8 million compared to SEK 18.89 million a year ago. Basic loss per share from continuing operations was SEK 0.08 compared to SEK 0.04 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.394 SEK | -1.50% | +12.89% | +53.91% |
Apr. 26 | InDex Pharmaceuticals Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 05 | Index Pharmaceuticals Holding AB Announces Board Resignations | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+53.91% | 19.11M | |
+34.00% | 704B | |
+26.14% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+14.87% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |
- Stock Market
- Equities
- INDEX Stock
- News InDex Pharmaceuticals Holding AB
- InDex Pharmaceuticals Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2023